Cite
Fluorescent nanodiamonds engage innate immune effector cells: A potential vehicle for targeted anti-tumor immunotherapy.
MLA
Suarez-Kelly, Lorena P., et al. “Fluorescent Nanodiamonds Engage Innate Immune Effector Cells: A Potential Vehicle for Targeted Anti-Tumor Immunotherapy.” Nanomedicine: Nanotechnology, Biology & Medicine, vol. 13, no. 3, Apr. 2017, pp. 909–20. EBSCOhost, https://doi.org/10.1016/j.nano.2016.12.005.
APA
Suarez-Kelly, L. P., Campbell, A. R., Rampersaud, I. V., Bumb, A., Wang, M. S., Butchar, J. P., Tridandapani, S., Yu, L., Rampersaud, A. A., & IIICarson, W. E. (2017). Fluorescent nanodiamonds engage innate immune effector cells: A potential vehicle for targeted anti-tumor immunotherapy. Nanomedicine: Nanotechnology, Biology & Medicine, 13(3), 909–920. https://doi.org/10.1016/j.nano.2016.12.005
Chicago
Suarez-Kelly, Lorena P., Amanda R. Campbell, Isaac V. Rampersaud, Ambika Bumb, Min S. Wang, Jonathan P. Butchar, Susheela Tridandapani, Lianbo Yu, Arfaan A. Rampersaud, and William E. IIICarson. 2017. “Fluorescent Nanodiamonds Engage Innate Immune Effector Cells: A Potential Vehicle for Targeted Anti-Tumor Immunotherapy.” Nanomedicine: Nanotechnology, Biology & Medicine 13 (3): 909–20. doi:10.1016/j.nano.2016.12.005.